Skip to main content

Advertisement

SpringerLink
Log in

Clinical Oncology/Epidemiology

Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary - a new therapeutic approach?

  • Clinical Oncology/Epidemiology
  • Published:
British Journal of Cancer Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. ICRF Department of Medical Oncology, St. Bartholomew's Hospital, London, UK

    STA Malik

Authors
  1. STA Malik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. ML Slevin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malik, S., Slevin, M. Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary - a new therapeutic approach?. Br J Cancer 63, 410–411 (1991). https://doi.org/10.1038/bjc.1991.94

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1991.94

  • Springer Nature Limited

This article is cited by

Search

Navigation